These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39145961)

  • 1. Salivary CD44 and Total Protein Levels to Detect Risk for Oral and Oropharyngeal Cancer Recurrence: A Nonrandomized Clinical Trial.
    Franzmann EJ; Qi Y; Peifer S; Messer K; Messing B; Blanco RG; Khan Z; Fahkry C; Coffey C; Califano J
    JAMA Otolaryngol Head Neck Surg; 2024 Oct; 150(10):843-850. PubMed ID: 39145961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients.
    Cohen ER; Reis IM; Gomez-Fernandez C; Smith D; Pereira L; Freiser ME; Marotta G; Thomas GR; Sargi ZB; Franzmann EJ
    Oral Oncol; 2020 Jul; 106():104720. PubMed ID: 32325304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Stratification System for Oral Cancer Screening.
    Pereira LH; Reis IM; Reategui EP; Gordon C; Saint-Victor S; Duncan R; Gomez C; Bayers S; Fisher P; Perez A; Goodwin WJ; Hu JJ; Franzmann EJ
    Cancer Prev Res (Phila); 2016 Jun; 9(6):445-55. PubMed ID: 27020654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals.
    Raslan S; Smith DH; Reis IM; Peifer SJ; Forman G; Ezeh UC; Joshi P; Koester M; Buitron I; Al-Awady A; Halgowich J; Liu H; Gordon C; Hooper MW; Sweeny L; Franzmann EJ
    BMC Oral Health; 2024 Jul; 24(1):820. PubMed ID: 39030509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Cohen ER; Reis IM; Gomez C; Pereira L; Freiser ME; Hoosien G; Franzmann EJ
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):239-251. PubMed ID: 28397583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead Time to Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Patients With Low-Risk HPV Oropharynx Cancer.
    Califano J; Yousef A; Mostafa H; Valsamakis A; Zhang X; Batis N; Varghese C; Parish J; Forman M; Jarrett J; Messer K; Mehanna H
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):812-819. PubMed ID: 37498566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CD44 overexpression and application of concurrent chemoradiotherapy with cisplatin independently indicate excellent prognosis in patients with HPV-positive oropharyngeal cancer.
    Biesaga B; Kołodziej-Rzepa M; Janecka-Widła A; Słonina D; Halaszka K; Przewoźnik M; Mucha-Małecka A
    Tumour Biol; 2021; 43(1):99-113. PubMed ID: 34024796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.
    Lassig AAD; Joseph AM; Lindgren BR; Yueh B
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):670-678. PubMed ID: 28418447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels.
    Bell EB; Reis IM; Cohen ER; Almuhaimid T; Smith DH; Alotaibi F; Gordon C; Gomez-Fernandez C; Goodwin WJ; Franzmann EJ
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
    Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses.
    Franzmann EJ; Donovan MJ
    Expert Rev Mol Diagn; 2018 Oct; 18(10):837-844. PubMed ID: 30221559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
    Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
    Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
    Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.
    Dibble EH; Alvarez AC; Truong MT; Mercier G; Cook EF; Subramaniam RM
    J Nucl Med; 2012 May; 53(5):709-15. PubMed ID: 22492732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.